Source material behind every call on the tape.
Source: [CNBC](https://www.cnbc.com/2026/06/10/trump-inflation-cpi-iran-oil.html) The number one thing he was re-elected for, and he says he loves how high the inflation currently is? While also wanting to cut rates? >“You know what I really love? I love the inflation. You know why?” …
The next short interest update could be more important than today's price action. Nasdaq releases their short interest data during after hours today. Things I'm watching: \-Short interest above **8M shares** *(May 15: 6.53M shares)* \-Short float above **15%** *(May …
https://preview.redd.it/820j53jkgh6h1.png?width=1345&format=png&auto=webp&s=561273de2e2cba8cd95e1cec26fef0c023330d2c EA trades are my favorite set-up. This time of year, there are few and far between EA to play, but today I'm anxiously awaiting $ORCL earnings. My assessment: IV is cheap, so I'm play it from the long side. …
Inflation: 4.2% in May for the past year Wage growth: 3.4% in May for the past year. Americans are getting squeezed financially. This isn't just "bad vibes" about the economy. There is real pain, especially for middle-class olds. It's tough …
No one cares about my DD, stock cheap, should be less cheap. You all will justify this as being smart if it goes up, and dumb if it goes down anyway. 338 shares, $10,000 in calls of various strikes Enjoy …
**Note**: **I have a sizable position in ZoomInfo (GTM) and buying every day. Its a very big portion of my net worth, so I am biased. Do your own work. Think the stock will be at $7-$10/sh vs. $2.75 today.** …
240% ctb, steady on the line at 9$ with two major market crashes, updated info that they havent covered Hold steady boys
NKARTA has become an intriguing speculative investment for me because the company is developing natural killer (NK) cell therapies that could offer advantages over traditional cell therapies in terms of safety, scalability, and accessibility. While many biotechnology companies remain focused …